We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Handheld Multiplexed Biosensor Platform Tests Antibodies, Antigens and Molecular Targets Simultaneously

By LabMedica International staff writers
Posted on 30 May 2023

A pioneering, portable, multiplex biosensor platform has the ability to simultaneously test antibodies, antigens, and molecular targets, enabling handheld, laboratory-grade testing wherever required - from emergency rooms to battlefields. More...

This rugged, cost-effective, portable, user-friendly reader comprises a single-use biochip equipped with 32 graphene-based sensors. Each sensor can be individually configured to identify molecular, antigen, and antibody targets. This effectively puts a whole lab in the palm of the hand, allowing healthcare professionals to make timely decisions wherever needed and simplifying work processes with results available within minutes.

The HemBox biosensor system from Hememics Biotechnologies (Gaithersburg, MD, USA) is a handheld, robust, and environmentally durable analytical device desigend for rapid on-site detection. It can test for bio-hazards in water, soil, and infected individuals. Capable of identifying multiple biothreats simultaneously, the HemBox provides sensitive, selective, and measurable data in real-time. This data can be stored on the device and transferred once a Bluetooth-enabled device with a secure user account comes within range.

The HemBox works with HemChip, a multiplexed immuno-biosensor that delivers rapid, affordable, and real-time disease biomarker measurements anywhere in the world. This compact, portable, and disposable biosensor, configured for multiplexing, comes with a bioreceptor layer and a proprietary biochip, designed to detect pathogens swiftly and accurately with high sensitivity. Each HemChip integrates multiple biosensors to detect several pathogens simultaneously. Working together, the HemBox and HemChip interpret the signals emitted by the HemChip, providing the user with real-time test results in less than five minutes.

“I am extremely proud of what the company has achieved with the limited amount of resources,” said John Warden, Jr., CEO and Co-founder of Hememics Biotechnologies, Inc. “We have generated extremely favorable results from more than 100,000 biosensor experiments in the past nine months.”

Related Links:
Hememics Biotechnologies 


New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.